These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24825137)

  • 1. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.
    Flisiak I; Szterling-Jaworowska M; Baran A; Rogalska-Taranta M
    Clin Exp Dermatol; 2014 Jun; 39(4):461-7. PubMed ID: 24825137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR).
    Szterling-Jaworowska M; Baran A; Myśliwiec H; Flisiak I
    J Dermatolog Treat; 2018 Mar; 29(2):135-139. PubMed ID: 28621164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations.
    Flisiak I; Zaniewski P; Rogalska-Taranta M; Chodynicka B
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):302-7. PubMed ID: 21418334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of an epidermal growth factor in blood serum of males during topical treatment of psoriasis.
    Pietrzak A; Miturski R; Krasowska D; Postawski K; Lecewicz-Toruń B
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):1-5. PubMed ID: 10188141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.
    Flisiak I; Zaniewski P; Rogalska M; Myśliwiec H; Jaroszewicz J; Chodynicka B
    Cytokine; 2010 Dec; 52(3):225-9. PubMed ID: 20980160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
    Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of serum epidermal growth factor on progressive psoriasis vulgaris and regulation of Chinese herbal medicine for cleaving heat, cooling blood, and detoxicating on it].
    Ma LL; Chen PF; Luo F
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Aug; 28(8):733-5. PubMed ID: 18928101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.
    Flisiak I; Myśliwiec H; Chodynicka B
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):418-21. PubMed ID: 15987285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of psoriasis activity on metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in plasma and lesional scales.
    Flisiak I; Porebski P; Chodynicka B
    Acta Derm Venereol; 2006; 86(1):17-21. PubMed ID: 16585983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
    Ataseven A; Kesli R
    G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
    Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum levels of interleukin 21 are associated with disease severity in patients with psoriasis.
    He Z; Jin L; Liu ZF; Hu L; Dang EL; Feng ZZ; Li QJ; Wang G
    Br J Dermatol; 2012 Jul; 167(1):191-3. PubMed ID: 22356196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma.
    Lemos-González Y; Rodríguez-Berrocal FJ; Cordero OJ; Gómez C; Páez de la Cadena M
    Br J Cancer; 2007 May; 96(10):1569-78. PubMed ID: 17453000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity.
    Guo S; Zhang W; Wei C; Wang L; Zhu G; Shi Q; Li S; Ge R; Li K; Gao L; Gao T; Wang G; Li C
    Eur J Dermatol; 2013; 23(5):608-13. PubMed ID: 24135466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
    Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
    Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris.
    Nockowski P; Szepietowski JC; Ziarkiewicz M; Baran E
    Acta Dermatovenerol Croat; 2004; 12(1):2-6. PubMed ID: 15072741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.
    Boehncke S; Salgo R; Garbaraviciene J; Beschmann H; Hardt K; Diehl S; Fichtlscherer S; Thaçi D; Boehncke WH
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1187-93. PubMed ID: 21241371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients.
    Jantus-Lewintre E; Sirera R; Cabrera A; Blasco A; Caballero C; Iranzo V; Rosell R; Camps C
    Clin Lung Cancer; 2011 Sep; 12(5):320-7. PubMed ID: 21729651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.